Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Mahé

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 6, 2024
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global surveyNicola Potere, Isabelle Mahé, Pantep Angchaisuksiri, et al.
Bulletin Du Cancer|August 30, 2008
[2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients]Philippe Debourdeau, Dominique Farge-Bancel, Lise Bosquet, et al.
Presse Medicale (Paris, France : 1983)|January 17, 2009
[Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients]Antoine Elias, Philippe Debourdeau, Jean Marc Renaudin, et al.
Journal Des Maladies Vasculaires|November 15, 2008
[2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients], Isabelle Mahé, Ismail Elalamy, et al.
Medicine|October 6, 2020
A strobe multicenter descriptive study of 55 infectious aortitisLouis Journeau, Marine de la Chapelle, Thomas Guimard, et al.
British Journal of Haematology|September 1, 2025
Anti-thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population-linked routinely collected dataSarah J Aldridge, Ashley Akbari, Adrian Edwards, et al.
Chest|October 10, 2021
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized TrialBenjamin Planquette, Laurent Bertoletti, Anaïs Charles-Nelson, et al.
Thrombosis Research|February 3, 2024
Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trialSérine Chaibi, Pierre-Marie Roy, Armelle Arnoux Guénégou, et al.
Research and Practice in Thrombosis and Haemostasis|May 4, 2026
Prescribing patterns and clinician preferences for direct oral anticoagulant use in unusual site venous thromboembolism: a cross-sectional analysis from the Direct oral anticoagulants in Unusual Site venous Thromboembolism (DUST) studyNicoletta Riva, Laurent Bertoletti, Antonio Chistolini, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Journal of Thrombosis and Haemostasis : JTH|April 6, 2024
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global surveyNicola Potere, Isabelle Mahé, Pantep Angchaisuksiri, et al.
Bulletin Du Cancer|August 30, 2008
[2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients]Philippe Debourdeau, Dominique Farge-Bancel, Lise Bosquet, et al.
Presse Medicale (Paris, France : 1983)|January 17, 2009
[Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients]Antoine Elias, Philippe Debourdeau, Jean Marc Renaudin, et al.
Journal Des Maladies Vasculaires|November 15, 2008
[2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients], Isabelle Mahé, Ismail Elalamy, et al.
Medicine|October 6, 2020
A strobe multicenter descriptive study of 55 infectious aortitisLouis Journeau, Marine de la Chapelle, Thomas Guimard, et al.
British Journal of Haematology|September 1, 2025
Anti-thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population-linked routinely collected dataSarah J Aldridge, Ashley Akbari, Adrian Edwards, et al.
Chest|October 10, 2021
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized TrialBenjamin Planquette, Laurent Bertoletti, Anaïs Charles-Nelson, et al.
Thrombosis Research|February 3, 2024
Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trialSérine Chaibi, Pierre-Marie Roy, Armelle Arnoux Guénégou, et al.
Research and Practice in Thrombosis and Haemostasis|May 4, 2026
Prescribing patterns and clinician preferences for direct oral anticoagulant use in unusual site venous thromboembolism: a cross-sectional analysis from the Direct oral anticoagulants in Unusual Site venous Thromboembolism (DUST) studyNicoletta Riva, Laurent Bertoletti, Antonio Chistolini, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
Pageof 15